26 February 2026 | 7:33AM CST Equity Research United Imaging (688271.SS): FY25 prelim results beat with strong 4Q25 performance; Buy United Imaging released its FY25 preliminary results on Feb 25, 2026. Both its revenue (Rmb13,821mn, +34% yoy) and net profit (Rmb1,888mn, +50% yoy) beat GSe (Rmb12,574mn/1,616mn). This prelim results implied a +48% yoy revenue growth in 4Q25, and we anticipate +44%/+61% yoy growth for the company's China domestic and overseas businesses in 4Q25, which translate to +30%/+49% y ...

Solventum Reports Fourth Quarter 2025 Financial Results and Introduces 2026 Full-Year Guidance [Accessibility Statement] Skip Navigation- Introduces full-year 2026 organic sales growth, adjusted EPS and free cash flow guidance- Reported sales decreased 3.7%; organic sales increased 3.5%ST. PAUL, Minn., Feb. 26, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results for the fourth quarter and year ended December 31, 2025.Fourth Quarter 2025 Highlights- Operating cash flow of $96 million ...

Xtant Medical to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference [Accessibility Statement] Skip NavigationBELGRADE, Mont., Feb. 25, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and wound care disorders, today announced that Sean Browne, CEO, Scott Neils, CFO, and Mark Schallenberger, COO, will be participating in the Canaccord Genuity 2026 Musculoskeleta ...

[https://mma.prnewswire.com/media/2855663/Polaroid_Theraphuetics_Logo.jpg]SOURCE Polaroid Therapeutics## 21%[more press release views with Request a Demo]## Also from this source### Polaroid Therapeutics (PTx) recibe la marca CE para POLTX_Fiberâ"¢[Polaroid Therapeutics (PTx) anuncia hoy que POLTX_Fiberâ"¢ ha recibido la marca CE como dispositivo médico de Clase IIb con APTâ"¢ (TecnologÃa de...]### Polaroid Therapeutics (PTx) erhält das CE-Zeichen für POLTX-Fiber™: die erste Anwendung von APT™ zur Einführun ...

Key Takeaways HSIC beat Q4 earnings and revenue estimates as sales rose 7.8% year over year. HSIC saw strong growth in equipment, specialty products and cloud-based tech adoption. Margins narrowed as gross margin fell 19 bps and adjusted operating margin slipped 57 bps. Henry Schein, Inc. (HSIC) registered fourth-quarter 2025 adjusted earnings per share (EPS) of $1.34, up 12.6% from the year-ago period’s figure. The bottom line also surpassed the Zacks Consensus Estimate by 3.1%.Excluding adjustments, such ...

Novanta (NasdaqGS:NOVT) Q4 2025 Earnings call February 24, 2026 08:00 AM ET Company ParticipantsMatthijs Glastra - Chair and CEORay Nash - Corporate Finance LeaderRobert Buckley - CFOConference Call ParticipantsBrian Drab - Equity Research AnalystLee Jagoda - Equity Research AnalystRob Mason - Managing Director and Senior Research AnalystOperatorAlso note, today's event is being recorded. At this time, I'd like to turn the conference call over to Ray Nash, Corporate Finance Leader for Novanta. Please go ahe ...

Stryker launches Synchfixâ"¢ EVT, expanding options for flexible syndesmotic fixation [Accessibility Statement] Skip NavigationElevating care with Stryker's next generation device, [Synchfix EVT], which will be featured at the 2026 American College of Foot and Ankle Surgeons (ACFAS) Annual MeetingPORTAGE, Mich., Feb. 24, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of Synchfixâ"¢ EVT, its next-generation flexible syndesmotic fixation device designed ...

Skip to main content Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv Henry Schein beats quarterly profit estimates on strong dental, medical equipment sales February 24, 20261:40 PM UTCUpdated ago By Reuters Feb 24 (Reuters) - Henry Schein (HSIC.O), opens new tab on Tuesday beat fourth-quarter profit estimates and forecast annual profit largely in line with Wall Street expectations on the back of stabilizing demand for its dental and medical equipment. After a ...

MiniMed announces launch of IPO roadshow [Accessibility Statement] Skip NavigationGALWAY, Ireland, Feb. 24, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed), a subsidiary of Medtronic plc (Medtronic) (NYSE: MDT), today announced that it has launched a roadshow for the initial public offering (IPO) of 28,000,000 shares of its common stock. The proposed offering is part of Medtronic's previously announced plan to separate its Diabetes business into an independent public company.The IPO price is currently ex ...

Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology [Accessibility Statement] Skip Navigation--BOSTON, Feb. 23, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the NexSys PCS® Plasma Collection System with Persona® PLUS technology. Persona PLUS represent ...